Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

2.

Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations.

Marroni F, Aretini P, D'Andrea E, Caligo MA, Cortesi L, Viel A, Ricevuto E, Montagna M, Cipollini G, Ferrari S, Santarosa M, Bisegna R, Bailey-Wilson JE, Bevilacqua G, Parmigiani G, Presciuttini S.

J Med Genet. 2004 Apr;41(4):278-85. No abstract available.

3.

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group.

Science. 2003 Oct 24;302(5645):643-6.

4.

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709.

5.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.

J Clin Oncol. 2002 Jun 1;20(11):2701-12.

PMID:
12039933
6.

Understanding mathematical models for breast cancer risk assessment and counseling.

Euhus DM.

Breast J. 2001 Jul-Aug;7(4):224-32. Review.

PMID:
11678799
7.

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT.

J Clin Oncol. 2001 Oct 15;19(20):4074-80.

PMID:
11600610
8.

Human disease genes.

Jimenez-Sanchez G, Childs B, Valle D.

Nature. 2001 Feb 15;409(6822):853-5.

PMID:
11237009
10.

Risk models for familial ovarian and breast cancer.

Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF.

Genet Epidemiol. 2000 Feb;18(2):173-90.

PMID:
10642429
11.

Genetic susceptibility to non-polyposis colorectal cancer.

Lynch HT, de la Chapelle A.

J Med Genet. 1999 Nov;36(11):801-18. Review.

12.

Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.

Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT.

J Gastrointest Surg. 1998 Jan-Feb;2(1):67-71.

PMID:
9841970
13.

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, et al.

Am J Hum Genet. 1998 Mar;62(3):676-89.

14.

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Parmigiani G, Berry D, Aguilar O.

Am J Hum Genet. 1998 Jan;62(1):145-58.

15.

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA.

N Engl J Med. 1997 May 15;336(20):1401-8.

16.

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E.

J Natl Cancer Inst. 1997 Feb 5;89(3):227-38.

PMID:
9017003
17.

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM.

Gastroenterology. 1996 Apr;110(4):1020-7. Erratum in: Gastroenterology 1996 Nov;111(5):1402.

PMID:
8612988
18.

Quantitating familial cancer risk: a resource for clinical oncologists.

Offit K, Brown K.

J Clin Oncol. 1994 Aug;12(8):1724-36. Review.

PMID:
8040684
19.

A general model for the genetic analysis of pedigree data.

Elston RC, Stewart J.

Hum Hered. 1971;21(6):523-42. No abstract available.

PMID:
5149961
20.

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

Newman B, Austin MA, Lee M, King MC.

Proc Natl Acad Sci U S A. 1988 May;85(9):3044-8.

Supplemental Content

Support Center